These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31357899)

  • 1. Scale-up production, characterization and toxicity of a freeze-dried lipid-stabilized microbubble formulation for ultrasound imaging and therapy.
    Unga J; Kageyama S; Suzuki R; Omata D; Maruyama K
    J Liposome Res; 2020 Sep; 30(3):297-304. PubMed ID: 31357899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of stability and ultrasound response of DSPC-DPSG-based freeze-dried microbubbles.
    Unga J; Omata D; Kudo N; Ueno S; Munakata L; Shima T; Suzuki R; Maruyama K
    J Liposome Res; 2019 Dec; 29(4):368-374. PubMed ID: 30526185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Bubble Concentration on the in Vitro and in Vivo Performance of Highly Stable Lipid Shell-Stabilized Micro- and Nanoscale Ultrasound Contrast Agents.
    Abenojar EC; Nittayacharn P; de Leon AC; Perera R; Wang Y; Bederman I; Exner AA
    Langmuir; 2019 Aug; 35(31):10192-10202. PubMed ID: 30913884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and characterization of echogenic lipid-Pluronic nanobubbles.
    Krupka TM; Solorio L; Wilson RE; Wu H; Azar N; Exner AA
    Mol Pharm; 2010 Feb; 7(1):49-59. PubMed ID: 19957968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Ultrasound Contrast Imaging of Tumor Vasculature With Positively Charged Microbubbles.
    Diakova GB; Du Z; Klibanov AL
    Invest Radiol; 2020 Nov; 55(11):736-740. PubMed ID: 32569011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of contrast agent destruction.
    Chomas JE; Dayton P; Allen J; Morgan K; Ferrara KW
    IEEE Trans Ultrason Ferroelectr Freq Control; 2001 Jan; 48(1):232-48. PubMed ID: 11367791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling the size distribution of lipid-coated bubbles via fluidity regulation.
    Wang CH; Yeh CK
    Ultrasound Med Biol; 2013 May; 39(5):882-92. PubMed ID: 23453628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of Microbubbles for Targeted Ultrasound Contrast Imaging: Practical Translation Considerations.
    Unnikrishnan S; Du Z; Diakova GB; Klibanov AL
    Langmuir; 2019 Aug; 35(31):10034-10041. PubMed ID: 30509068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On-chip preparation of nanoscale contrast agents towards high-resolution ultrasound imaging.
    Peyman SA; McLaughlan JR; Abou-Saleh RH; Marston G; Johnson BR; Freear S; Coletta PL; Markham AF; Evans SD
    Lab Chip; 2016 Feb; 16(4):679-87. PubMed ID: 26689151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Freeze-Dried Microfluidic Monodisperse Microbubbles as a New Generation of Ultrasound Contrast Agents.
    Soysal U; Azevedo PN; Bureau F; Aubry A; Carvalho MS; Pessoa ACSN; Torre LG; Couture O; Tourin A; Fink M; Tabeling P
    Ultrasound Med Biol; 2022 Aug; 48(8):1484-1495. PubMed ID: 35568594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preserving the Integrity of Surfactant-Stabilized Microbubble Membranes for Localized Oxygen Delivery.
    Oeffinger BE; Vaidya P; Ayaz I; Shraim R; Eisenbrey JR; Wheatley MA
    Langmuir; 2019 Aug; 35(31):10068-10078. PubMed ID: 30827115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution.
    Ohshima H; Miyagishima A; Kurita T; Makino Y; Iwao Y; Sonobe T; Itai S
    Int J Pharm; 2009 Jul; 377(1-2):180-4. PubMed ID: 19446623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting and ultrasound imaging of microbubble-based contrast agents.
    Klibanov AL; Hughes MS; Villanueva FS; Jankowski RJ; Wagner WR; Wojdyla JK; Wible JH; Brandenburger GH
    MAGMA; 1999 Aug; 8(3):177-84. PubMed ID: 10504045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved water dispersibility and photostability in folic acid nanoparticles with transglycosylated naringin using combined processes of wet-milling and freeze-drying.
    Semba K; Kadota K; Arima H; Nakanishi A; Tandia M; Uchiyama H; Sugiyama K; Tozuka Y
    Food Res Int; 2019 Jul; 121():108-116. PubMed ID: 31108730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the potential of doxorubicin loaded microbubbles as a theranostic modality using a murine tumor model.
    Abdalkader R; Kawakami S; Unga J; Suzuki R; Maruyama K; Yamashita F; Hashida M
    Acta Biomater; 2015 Jun; 19():112-8. PubMed ID: 25795624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound contrast agents: basic principles.
    Calliada F; Campani R; Bottinelli O; Bozzini A; Sommaruga MG
    Eur J Radiol; 1998 May; 27 Suppl 2():S157-60. PubMed ID: 9652516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbubble characterization through acoustically induced deflation.
    Guidi F; Vos HJ; Mori R; de Jong N; Tortoli P
    IEEE Trans Ultrason Ferroelectr Freq Control; 2010 Jan; 57(1):193-202. PubMed ID: 20040446
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.